Get the Stockscreener App
1.10
0.90%
-0.01
After Hours:
1.07
-0.03
-2.73%
Nuwellis Inc stock is traded at $1.10, with a volume of 24,563.
It is down -0.90% in the last 24 hours and down -31.68% over the past month.
Nuwellis Inc is a commercial-stage medical device company focused on advancing precision cardiorenal care in critical care settings through the development, manufacture, and commercialization of the Aquadex SmartFlow system for ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
See More
Previous Close:
$1.11
Open:
$1.09
24h Volume:
24,563
Relative Volume:
0.01
Market Cap:
$2.54M
Revenue:
$8.27M
Net Income/Loss:
$-17.52M
P/E Ratio:
-0.0176
EPS:
-62.6089
Net Cash Flow:
$-10.90M
1W Performance:
+1.85%
1M Performance:
-31.68%
6M Performance:
-69.44%
1Y Performance:
-3.51%
1-Day Range:
$1.0301
$1.11
1-Week Range:
$0.96
$1.1699
52-Week Range:
$0.19
$25.95
Nuwellis Inc Stock (NUWE) Company Profile
Name
Nuwellis Inc
Sector
Industry
Phone
952-345-4200
Address
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Compare NUWE vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
1.10 | 2.56M | 8.27M | -17.52M | -10.90M | -62.61 |
ABT
Abbott Laboratories
|
104.06 | 182.20B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.51 | 127.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.58 | 111.92B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
68.15 | 103.35B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.69 | 47.64B | 6.07B | 1.06B | 1.34B | 1.8063 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | ROTH MKM | Buy |
Nuwellis Inc Stock (NUWE) Latest News
Investment Report: Does Nuwellis Inc have pricing power2026 EndofYear Setup & Long-Term Safe Return Strategies - baoquankhu1.vn
Nuwellis (NASDAQ: NUWE) director Emerson Martin J submits initial Form 3 - Stock Titan
Nuwellis completes acquisition of Rendiatech for renal monitoring By Investing.com - Investing.com South Africa
CEO Moves: How correlated is VIVK to the S P5002026 Closing Moves & High Accuracy Buy Signal Tips - baoquankhu1.vn
NUWE SEC FilingsNuwellis Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Nuwellis, Inc. completed the acquisition of Rendiatech Ltd. - marketscreener.com
Nuwellis completes acquisition of Rendiatech for renal monitoring - Investing.com
Nuwellis completes acquisition of Rendiatech, expanding technology portfolio - Investing.com
Nuwellis, Inc. Completes Acquisition of Rendiatech, Expanding Automated Kidney Monitoring Technology Portfolio - Minichart
Nuwellis (NUWE) Finalizes Acquisition of Israeli Tech Firm Rendi - GuruFocus
Nuwellis Completes Acquisition of Kidney Monitoring Innovator Rendiatech - TipRanks
Nuwellis Completes Acquisition of Rendiatech - Bitget
Nuwellis (NASDAQ: NUWE) closes deal for Rendiatech kidney monitoring tech - Stock Titan
Nuwellis buys new kidney monitors to guide earlier care for sickest patients - Stock Titan
Nuwellis, Inc. (NASDAQ: NUWE) Q4 2025 earnings call transcript - MSN
Nuwellis (NUWE) Q4 2025 Earnings Call Transcript - AOL.com
Nuwellis, Inc. 2026 Annual Report: Aquadex System Market, Risks, and Regulatory Overview - Minichart
Nuwellis Q4 Earnings Call Highlights - Defense World
Nuwellis 10-K: $8.27M Revenue, $(25.39) Loss Per Share - TradingView
Nuwellis, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 - marketscreener.com
Nuwellis Inc (NUWE) Reports Q4 Earnings - AlphaStreet
Nuwellis Earnings Call: Margin Gains Amid Cash Strain - TipRanks
Earnings call transcript: Nuwellis Q4 2025 sees strategic shifts amid revenue growth - Investing.com Nigeria
Earnings call transcript: Nuwellis Q4 2025 sees strategic shifts amid revenue growth By Investing.com - Investing.com South Africa
Nuwellis (NUWE) Q4 2025 revenue rises 4% as yearly loss widens - Stock Titan
Nuwellis, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Nuwellis (NUWE) Reports Increased Q4 Revenue Amidst Strategic Re - GuruFocus
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results - Bitget
BRIEF-Nuwellis Q4 EPS USD -1.5 - TradingView
Nuwellis Q4 2025 Earnings Call Transcript - MarketBeat
Nuwellis Earnings Preview - Benzinga
Nuwellis Inc expected to post a loss of $1.56 a shareEarnings Preview - TradingView
Nuwellis appoints Stuart Goldstein as clinical strategy director By Investing.com - Investing.com Canada
Nuwellis appoints Stuart Goldstein as clinical strategy director - Investing.com Nigeria
Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy - Bitget
NUWEForm PRE 14AOther preliminary proxy statements - ADVFN Ltd
Nuwellis (NUWE) director David McDonald reports nonstatutory option holdings - Stock Titan
NUWE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
NUWE Technical Analysis & Stock Price Forecast - Intellectia AI
Nuwellis adds two directors with medical device experience By Investing.com - Investing.com Australia
Nuwellis Expands Board With New Independent Financial Experts - TipRanks
Nuwellis adds two directors with medical device experience - Investing.com
Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors - The Manila Times
Nuwellis Inc Stock (NUWE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.69%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):